Holen Sie sich die Stockscreener-App
0.2105
3.17%
-0.0069
Handel nachbörslich:
.21
-0.0005
-0.24%
Biorestorative Therapies Inc Aktie (BRTX) Neueste Nachrichten
BioRestorative Therapies, Inc. to Participate in the Be+Well Beauty and Wellness Show in New York City, March 8-10, 2026 - Bitget
BioRestorative Therapies, Inc. to Participate in the - GlobeNewswire
BRTX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
BioRestorative Therapies, Inc. Issues Letter to Shareholders Highlighting Major Milestones, Regulatory Alignment, Clinical Execution and Capital Strategy - Yahoo Finance
BioRestorative Therapies Inc expected to post a loss of 36 cents a shareEarnings Preview - TradingView
Aug Breakouts: Whats the beta of BioRestorative Therapies Inc stockJuly 2025 Short Interest & Risk Managed Investment Signals - baoquankhu1.vn
Meme Stocks: Is BioRestorative Therapies Inc a speculative investmentAnalyst Downgrade & Entry Point Confirmation Alerts - baoquankhu1.vn
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
BioRestorative Expands Global Protection for ThermoStem®, a Potentially Longer-Lasting and Safer Cell-Based Alternative to GLP-1 Drugs - The Globe and Mail
Biorestorative expands global protection for ThermoStem - marketscreener.com
BioRestorative Therapies Receives Patent Approval for Innovative Brown Adipose-Derived Stem Cell Technology Targeting Obesity and Metabolic Disorders - Quiver Quantitative
Australia clears patent for cell therapy touted as GLP-1 alternative - Stock Titan
BioRestorative (NASDAQ: BRTX) amendment shows no beneficial ownership by filer - Stock Titan
Geopolitics Watch: Whats the beta of BioRestorative Therapies Inc stockTrade Exit Report & Safe Swing Trade Setups - baoquankhu1.vn
What’s the MACD signal for BioRestorative Therapies Inc.2025 Short Interest & Daily Profit Maximizing Tips - mfd.ru
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
BioRestorative concludes Phase II BRTX-100 trial enrolment for cLDD - MSN
Degenerative Disc Disease Clinical Trial Pipeline Strengthens as 15+ Companies Advance 15+ Regenerative and Non‑Surgical Therapies Toward Market Entry, Finds DelveInsight | Spine BioPharma, Biosplice - Barchart.com
BioRestorative Therapies Raises ~$5 Million in Unit Offering; Issues Five-Year Warrants - TradingView
Will BioRestorative Therapies Inc. stock go up in YEAR2025 Trade Ideas & Verified Stock Trade Ideas - mfd.ru
Aug Levels: Is Antero Midstream Corporation stock showing strong momentum2025 Momentum Check & Target Return Focused Picks - baoquankhu1.vn
BioRestorative Therapies closes $5 million public offering By Investing.com - Investing.com Nigeria
BRTX PE Ratio & Valuation, Is BRTX Overvalued - Intellectia AI
Biorestorative Therapies (NASDAQ:BRTX) Trading 5.9% Higher – Still a Buy? - Defense World
BioRestorative Therapies, Inc. Completes Public Offering Raising Approximately $5.0 Million for Clinical and Research Initiatives - Quiver Quantitative
BRTX Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
BioRestorative Closes $5 Million Public Offering of 14.3 Million Shares - Intellectia AI
BioRestorative Therapies closes $5 million public offering - Investing.com
BioRestorative Announces Closing of $5.0 Million Public Offering - Bitget
Stem cell firm BioRestorative raises $5M for trials and R&D - Stock Titan
BioRestorative Announces Closing of $5.0 Million Public Offering - GlobeNewswire Inc.
BioRestorative prices $5M stock offering - MSN
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
Form 424B4 BioRestorative Therapies - StreetInsider
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
Published on: 2026-02-12 18:49:00 - mfd.ru
BioRestorative Therapies stock plunges after $5 million public offering By Investing.com - Investing.com Nigeria
BioRestorative Therapies stock plunges after $5 million public offering - Investing.com South Africa
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
BioRestorative Therapies (OTCMKTS:BRTXQ) Shares Down 38.9%Here's Why - MarketBeat
BioRestorative Therapies Announces $5 Million Public Offering to Fund Operations - geneonline.com
BioRestorative Announces Pricing of $5.0 Million Public Offering - The Manila Times
Stem cell developer BioRestorative seeks $5M for BRTX-100 trials - Stock Titan
BioRestorative announces pricing of $5.0 million public offering - marketscreener.com
Is BioRestorative Therapies Inc.’s growth already priced inWeekly Trade Report & Daily Risk Controlled Trade Plans - mfd.ru
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
BioRestorative Therapies, Inc. Announces Positive Outcome from Type B Meeting with FDA - marketscreener.com
BioRestorative Announces Positive Outcome From Type B Meeting With FDA - Nasdaq
Biorestorative announces positive outcome from type B meeting with FDA - marketscreener.com
BioRestorative Therapies recently updated the timeline for its core research and development pipeline - Bitget
BioRestorative Therapies Receives Positive FDA Feedback on BRTX-100 Program for Accelerated BLA Approval Pathway - Quiver Quantitative
FDA meeting outlines expedited approval path for BioRestorative BRTX-100 - Stock Titan
Biorestorative completes patient enrollment in landmark phase 2 trial of BRTX-100 for chronic lumbar disc disease - marketscreener.com
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
BioRestorative Completes Patient Enrollment in Landmark Phase 2 Trial of BRTX-100 for Chronic Lumbar Disc Disease - GlobeNewswire
3.69%
0.68%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):